DrugsControl Media Services
DrugsControl.org

News Detail

Tirzepatide Reduces Time to HbA1c (17-09-2022)

Stockholm, 15 Sept 2022: Tirzepatide (Mounjaro, Eli Lilly) was associated with more rapid achievement of glycemic targets and weight loss goals in patients withView Details

Source : Patient Care
Diabetes Type 2 Weight Management Obesity Tirzepatide

Related News